RSPO1 and skin squamous cell carcinoma: In addition, mutations in encoding R-spondin1 (RSPO1) lead to an extremely rare clinical syndrome that combines SRY-negative XX male sex reversal with palmoplantar hyperkeratosis, and a predisposition to squamous cell carcinoma of the skin (14).